Cytecare Hospitals Private Limited, a active private limited company, was established on 11 March 2014 in Ahmedabad, Gujarat, India. Engaging in oncology clinics & cancer treatment within the hospital and medical care sector, it holds CIN: U85110GJ2014PTC079078. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹2.73 Cr and a paid-up capital of ₹4.86 M.
Formerly known as Medela Hospitals Private Limited. It upholds a compliant status. Employing 256 professional, Its leadership includes Ferzaan Nariman Engineer (Director), Mohan Vamsy Chigurupati (Additional Director), Padmaja Chigurupati (Additional Director). Past directors included Ridhi Chaudhary, Suresh Ramu, Lavanya Ashok. It holds ₹36.15 Cr open charges and ₹15.00 Cr settled loans. Its latest AGM occurred on 13 September 2024, with the balance sheet filed on 31 March 2024. It is based at 105/A, Shagun Complex, B-93 Swastik Society, C.G.Road, Navrangpura, Ahmedabad, Gujarat, 380009.
U85110GJ2014PTC079078
079078
11 March 2014
₹2.73 Cr
₹4.86 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Cytecare Hospitals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ferzaan Nariman Engineer | Director | 15 Jun 2014 | Current |
| Mohan Vamsy Chigurupati | Additional Director | 03 Nov 2025 | Current |
| Padmaja Chigurupati | Additional Director | 03 Nov 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 17 Mar 2021 | Past |
| Pramod Abcsdd | Director | 22 May 2018 | Past |
| Pramod Abcsdd | Additional Director | 08 Jun 2018 | Past |
| Pramod Abcsdd | Director | 22 May 2018 | Past |
| Pramod Abcsdd | Director | 01 Nov 2023 | Past |
| Pramod Abcsdd | Director | 16 Jun 2024 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Cytecare Hospitals Private Limited, for the financial year ended 2024, experienced significant growth in revenue, with a 18.72% increase. The company also saw a substantial improvement in profitability, with a 60.15% increase in profit. The company's net worth observed a substantial decline by a decrease of 48.57%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2024, Cytecare Hospitals had a promoter holding of 5.61% and a public holding of 94.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹361,495,875.00
₹150,000,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 18 Sep 2024 | Others | ₹5.00 Cr | Open |
| 14 Mar 2024 | Hdfc Bank Limited | ₹5.78 M | Open |
| 01 Mar 2024 | Standard Chartered Bank | ₹8.50 M | Open |
| 01 Mar 2024 | Standard Chartered Bank | ₹6.50 M | Open |
| 09 Jan 2024 | Others | ₹5.00 M | Open |
Explore comprehensive loan charge details -
Cytecare Hospitals has a workforce of 256 employees as of Aug 19, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Cytecare Hospitals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Cytecare Hospitals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mohan Vamsy Chigurupati was appointed as a Additional Director was appointed as a Additional Director on 03 Nov 2025 & has been associated with this company since 1 month 13 days . was recorded as a recent event.
Progress on Padmaja Chigurupati was appointed as a Additional Director was appointed as a Additional Director on 03 Nov 2025 & has been associated with this company since 1 month 13 days . was documented.
A charge with Hdfc Bank Limited of Rs. 15.84 Cr registered on 14 Jul 2017 with Charge ID 100117155 was modified on 03 Feb 2025. was recorded as a recent event.
A charge with Others amounted to Rs. 5.00 Cr with Charge ID 100985397 was registered on 18 Sep 2024. was recorded as a recent event.
The activity A charge registered on 15 Dec 2023 via Charge ID 100866617 with Others was fully satisfied on 16 Sep 2024. was completed.
The activity Cytecare Hospitals Private Limited last Annual general meeting of members was held on 13 Sep 2024 as per latest MCA records. was completed.
Cytecare aims to advance its mission to provide holistic healthcare solutions Cytecare Hospitals in collaboration with Humanist Centre for Medicine (Humanist), (a Bengaluru-based NGO, that aims to bri.
The CIN of Cytecare Hospitals Private Limited is U85110GJ2014PTC079078.
Cytecare Hospitals Private Limited is headquartered at 105/A, Shagun Complex, B-93 Swastik Society, C.G.Road, Navrangpura, Ahmedabad, Gujarat, 380009.
Cytecare Hospitals Private Limited was incorporated on 11 March 2014.
The current directors of Cytecare Hospitals Private Limited are
The primary industry of Cytecare Hospitals Private Limited is Hospital And Medical Care.
Cytecare Hospitals Private Limited is unlisted.
The authorized capital of Cytecare Hospitals Private Limited is ₹2.73 Cr, and the paid-up capital is ₹4.86 M.
The compliance status of Cytecare Hospitals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX